Clinical trial

Seizure Activity in Alzheimer's Disease

NCT01554683

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhaseNA

Study timeline

Study start (unknown)2012-02-01Date precision: month

Registry last updated2020-07-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Seizuresunresolved

Interventions

Low/High/Placebo Dose Keppra (Levetiracetam)DRUG

Sponsors & collaborators

Beth Israel Deaconess Medical Centerlead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01554683 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.